.

Pharmaceutical Business Intelligence

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

MERREM Drug Profile

« Back to Dashboard

Which patents cover Merrem, and what substitute generic drugs are available?

Merrem is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in MERREM is meropenem. There are thirty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the meropenem profile page.

Summary for Tradename: MERREM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list73
Clinical Trials: see list2
Patent Applications: see list3,914
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MERREM at DailyMed

Pharmacology for Tradename: MERREM

Ingredient-typeCarbapenems
Drug ClassPenem Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
MERREM
meropenem
INJECTABLE;INJECTION050706-001Jun 21, 1996RXYesYes► Subscribe► Subscribe
Astrazeneca
MERREM
meropenem
INJECTABLE;INJECTION050706-003Jun 21, 1996RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: MERREM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
MERREM
meropenem
INJECTABLE;INJECTION050706-001Jun 21, 19964,943,569► Subscribe
Astrazeneca
MERREM
meropenem
INJECTABLE;INJECTION050706-003Jun 21, 19964,943,569► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc